Upgrade to SI Premium - Free Trial

Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital

August 11, 2026 7:57 AM
(Updated - August 11, 2026 10:02 AM EDT)

RBC Capital analyst Leonid Timashev raised the price target on Biohaven ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change